MetaCap

Cytek Biosciences Statistics

NASDAQ: CTKBIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD

6.12-0.20 (-3.16%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Cytek Biosciences by the numbers

Cytek Biosciences has a market capitalization of $800.4 million based on 130.78M shares outstanding. With trailing EPS of $-0.63, Cytek Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.7% above its 50-day average and 30.2% above its 200-day average.

Average daily trading volume is 1.31M shares, or about $8.0 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CTKB valuation vs. peer median

CTKB compared with the median of 8 peer companies
MetricCTKBPeer medianDifference
Market cap$800.40M$84.48M+847%
Avg. volume1.31M649.32K+102%

Peer median across 8 companies: PACB, NAUT, LAB, QTRX, SEER, HBIO, RPID, PRPO.

Valuation

Market cap
$800.40M
Price / sales (latest FY)
3.97
EPS (TTM)
$-0.63

Price and trading

Previous close
6.32
Open
6.28
Day range
5.99 – 6.39
52-week range
3.31 – 6.39
52-week change
+4.08%
Beta
—
Volume
1.77M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
800.40M
Forward Pe
87.43
Eps
-0.63
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
6.39
Week52 Low
3.31
Avg Volume
1.31M
Shares Outstanding
130.78M
Ma50
5.63
Ma200
4.70
Earnings Date
Nov 4, 2026
Pct From52w High
-4.15%
Pct From52w Low
84.89%

Related